IceCure Medical (NASDAQ:ICCM) Shares Down 0.4% – Here’s Why

IceCure Medical Ltd (NASDAQ:ICCM) shares were down 0.4% on Thursday . The company traded as low as $1.12 and last traded at $1.15. Approximately 341,936 shares traded hands during trading, a decline of 40% from the average daily volume of 574,286 shares. The stock had previously closed at $1.16.

Analysts Set New Price Targets

Several brokerages recently issued reports on ICCM. HC Wainwright reiterated a “buy” rating and issued a $2.50 price objective on shares of IceCure Medical in a report on Wednesday, November 27th. Alliance Global Partners raised IceCure Medical to a “strong-buy” rating in a research report on Friday, November 1st.

IceCure Medical Trading Down 2.6 %

The company has a current ratio of 2.67, a quick ratio of 2.27 and a debt-to-equity ratio of 0.02. The firm’s 50-day moving average is $0.75 and its 200 day moving average is $0.71. The firm has a market capitalization of $51.09 million, a price-to-earnings ratio of -3.86 and a beta of 0.50.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in IceCure Medical stock. Renaissance Technologies LLC bought a new position in shares of IceCure Medical Ltd (NASDAQ:ICCM) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 66,400 shares of the company’s stock, valued at approximately $49,000. Renaissance Technologies LLC owned 0.15% of IceCure Medical at the end of the most recent reporting period. 0.62% of the stock is currently owned by hedge funds and other institutional investors.

IceCure Medical Company Profile

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.